1. IkappaBalpha/IkappaBepsilon deficiency reveals that a critical NF-kappaB dosage is required for lymphocyte survival.
- Author
-
Goudeau B, Huetz F, Samson S, Di Santo JP, Cumano A, Beg A, Israël A, and Mémet S
- Subjects
- Animals, Base Sequence, Cell Survival, Gene Rearrangement immunology, I-kappa B Proteins genetics, Immunoglobulin Heavy Chains genetics, Immunoglobulin Light Chains genetics, Lymphocytes cytology, Mice, Mice, Knockout, NF-KappaB Inhibitor alpha, Oligonucleotide Probes, Polymerase Chain Reaction, Proto-Oncogene Proteins genetics, I-kappa B Proteins physiology, Lymphocytes immunology, NF-kappa B metabolism, Proto-Oncogene Proteins deficiency, Proto-Oncogene Proteins physiology
- Abstract
In most cells, the NF-kappaB transcription factor is sequestered in the cytoplasm by interaction with inhibitory proteins, the IkappaBs. Here, we show that combined IkappaBalpha/IkappaBepsilon deficiency in mice leads to neonatal death, elevated kappaB binding activity, overexpression of NF-kappaB target genes, and disruption of lymphocyte production. In IkappaBalpha/IkappaBepsilon-deficient fetuses, B220+IgM+ B cells and single-positive T cells die by apoptosis. In adults, IkappaBalpha-/-IkappaBepsilon-/- reconstituted chimeras exhibit a nearly complete absence of T and B cells that is not rescued by cotransfer with wild-type bone marrow. These findings demonstrate that IkappaBs tightly control NF-kappaB activity in vivo and that increased NF-kappaB activity intrinsically impairs lymphocyte survival. Because reduction or rise of NF-kappaB activity leads to similar dysfunction, they also reveal that only a narrow window of NF-kappaB activity is tolerated by lymphocytes.
- Published
- 2003
- Full Text
- View/download PDF